Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.


TSX:PRN - Post by User

Comment by MrMugsyon Dec 30, 2020 5:24pm
168 Views
Post# 32199944

RE:RE:christmas gift ...

RE:RE:christmas gift ...
retiredcf wrote: The SP is almost back to where it was at the beginning of the month (and before the TULSA-PRO announcement) so had to add a few more this morning. GLTA


Sounds good.  We need some renewed growth activity in the New Year - maybe something big with GE as well ???

Also need some updates on the Sonalleve strategy.  Before COvID, there were plans to move forward on a special project in Germany ... with partnership with gov.  Maybe a kickstart there and rare disease in USA in 2021.

Good Luck All !!!
<< Previous
Bullboard Posts
Next >>